|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Geometric control of stem cell differentiation rate on surfaces显示文摘 | LUO W JONES S R YOUSAF M N | 2008 | Langmuir2008，24，12： | 1 |
| 2 | Functional null mutations of MSRB3 encoding methionine sulfoxide reductase are associated with human deafness DFNB74 显示文摘 | Ahmed ZM Yousaf R Lee BC | 2011 | Am J Hum Genet2011，88，1： | 1 |
| 3 | Th17 cells:intemctions with predisposing factors in the immunopathogenesis of inflammatory bowel disease显示文摘 | Raza A Yousaf W Giannella R | 2012 | Expert Rev Clin Immunol2012，8，2： | 1 |
| 4 | Th17 cells: interactions with predisposing factors in theimmunopathogenesis of inflammatory bowel disease显示文摘 | Raza A Yousaf W Giannella R | 2012 | Expert RevClin Immunol2012，8，2： | 1 |
| 5 | Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease显示文摘 | Raza A Yousaf W Giannella R | 2012 | Expert Rev Clin Immunol2012，8，2： | 1 |
| 6 | Identification of micro-RNAs in cotton显示文摘 | Khan Barozai M Y Irfan M Yousaf R etal | 2008 | Plant Physiol Biochem2008，46，89： | 1 |
| 7 | Paraganglioma of u- rinary bladder: an unusual presentation, pitfalls in diagnosis and treatment显示文摘 | Ghafoor AU Yousaf I Pervez R | 2012 | J Pak Med Assoe2012，62，1： | 1 |
| 8 | Th17 cells : interac- tions with predisposing factors in the immuno pathogene- sis of inflammatory bowel disease显示文摘 | Raza A Yousaf W Giannella R | 2012 | Expert Rev Clin Immunol2012，8，2： | 1 |
| 9 | Thl7 cells:interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease显示文摘 | Raza A Yousaf W Giannella R | | 0，，02： | 1 |
| 10 | Impact of frailty on endoscopic retrograde cholangiopancreatography outcomes in nonagenarians:A United States national experience显示文摘BACKGROUND Endoscopic retrograde cholangiopancreatography(ERCP)is an essential therapeutic tool for biliary and pancreatic diseases.Frail and elderly patients,especially those aged≥90 years are generally considered a higher-risk population for ERCP-related complications.AIM To investigate outcomes of ERCP in the Non-agenarian population(≥90 years)concerning Frailty.METHODS This is a cohort study using the 2018-2020 National Readmission Database.Patients aged≥90 were identified who underwent ERCP,using the international classification of diseases-10 code with clinical modification.Johns Hopkins’s adjusted clinical groups frailty indicator was used to classify patients as frail and non-frail.The primary outcome was mortality,and the secondary outcomes were morbidity and the 30 d readmission rate related to ERCP.We used univariate and multivariate regression models for analysis.RESULTS A total of 9448 patients were admitted for any indications of ERCP.Frail and non-frail patients were 3445(36.46%)and 6003(63.53%)respectively.Indications for ERCP were Choledocholithiasis(74.84%),Biliary pancreatitis(9.19%),Pancreatico-biliary cancer(7.6%),Biliary stricture(4.84%),and Cholangitis(1.51%).Mortality rates were higher in frail group[adjusted odds ratio(aOR)=1.68,P=0.02].The Intra-procedural complications were insigni-ficant between the two groups which included bleeding(aOR=0.72,P=0.67),accidental punctures/lacerations(aOR=0.77,P=0.5),and mechanical ventilation rates(aOR=1.19,P=0.6).Post-ERCP complication rate was similar for bleeding(aOR=0.72,P=0.41)and post-ERCP pancreatitis(aOR=1.4,P=0.44).Frail patients had a longer length of stay(6.7 d vs 5.5 d)and higher mean total charges of hospitalization($78807 vs$71392)compared to controls(P<0.001).The 30 d all-cause readmission rates between frail and non-frail patients were similar(P=0.96).CONCLUSION There was a significantly higher mortality risk and healthcare burden amongst nonagenarian frail patients undergoing ERCP compared to non-frail.Larger studies are warranted to investigate and mitigate modifiable risk factors. | Sanket Dhirubhai Basida Dushyant Singh Dahiya Muhammad Nadeem Yousaf Brinda Basida Bhanu Siva Mohan Pinnam Manesh Kumar Gangwani Hassam Ali Sahib Singh Yash R Shah Daksh Ahluwalia Mihir Prakash Shah Saurabh Chandan Neil R Sharma Shyam Thakkar | 2024 | World Journal of Gastrointestinal Endoscopy2024，16，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员